Bridgeway Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.55M	Sell	2,620 -1,240	-32%	-$618K	0.03%	594
2025 Q4	$1.88M	Buy	+3,860	New	+$1.8M	0.04%	556
2018 Q2	–	Sell	-13,600	Closed	-$1.53M	–	1462
2018 Q1	$1.53M	Sell	13,600 -295,430	-96%	-$37.5M	0.02%	684
2017 Q4	$45.7M	Buy	309,030 +4,900	+2%	+$623K	0.49%	75
2017 Q3	$35.6M	Sell	304,130 -3,400	-1%	-$434K	0.41%	85
2017 Q2	$39.9M	Hold	307,530	–	–	0.48%	81
2017 Q1	$41.6M	Buy	307,530 +150,730	+96%	+$22.8M	0.5%	72
2016 Q4	$22.5M	Buy	156,800 +124,300	+382%	+$15.9M	0.29%	100
2016 Q3	$3.84M	Hold	32,500	–	–	0.06%	299
2016 Q2	$3.44M	Hold	32,500	–	–	0.05%	322
2016 Q1	$3.62M	Hold	32,500	–	–	0.06%	306
2015 Q4	$5.09M	Buy	32,500 +5,900	+22%	+$859K	0.09%	210
2015 Q3	$3.49M	Hold	26,600	–	–	0.07%	288
2015 Q2	$4.63M	Buy	+26,600	New	+$4.79M	0.09%	238
2013 Q4	–	Sell	-40,800	Closed	-$3.22M	–	1442
2013 Q3	$3.22M	Hold	40,800	–	–	0.11%	191
2013 Q2	$2.69M	Buy	+40,800	New	+$2.63M	0.11%	229